About KBio
KBio aims to create a new generation of biologics using its plant-based platform that has demonstrated the ability to create drug candidates at a fraction of the time and cost of conventional platforms. The Company is focused on developing novel product candidates in two core areas: 1) Antibody therapies for areas of high unmet need; and 2) Pandemic preparedness and response using its plant-based production system to create antibodies and vaccines in shorter timeframes than industry norms. Formed in December 2021, KBio is a subsidiary of BAT with operations in the UK and U.S.
- Founded
- 2022
- Employees
- 11 to 50
- Headquarters
- Owensboro
Leadership
The top of KBio's org chart, with how many people report into each leader.
Patrick Doyle
Chief Executive Officer
3 reports
Carmine Carpenito
Head of Research
1 report
Michael Church
Scientist
Jobs at KBio
No open positions right now. Explore more companies on TheJobsMap.